China Wah Yan Healthcare Limited provided earnings guidance for the full year ended December 31, 2017. The board of directors of the company announced that based on the latest available unaudited financial information of the group, the group expects to record a significant loss for the year ended December 31, 2017. Such loss is mainly attributable to the potential loss of HKD 222 million from investment in certain listed securities due to decline in their market value; and potential full impairment on certain listed securities (the shares) the trading in which on the Stock Exchange had been suspended under the direction of the Securities and Futures Commission.